International Journal of Molecular Sciences (Feb 2021)

HIV-1 Tat Activates Akt/mTORC1 Pathway and <i>AICDA</i> Expression by Downregulating Its Transcriptional Inhibitors in B Cells

  • Burkitkan Akbay,
  • Diego Germini,
  • Amangeldy K. Bissenbaev,
  • Yana R. Musinova,
  • Evgeny V. Sheval,
  • Yegor Vassetzky,
  • Svetlana Dokudovskaya

DOI
https://doi.org/10.3390/ijms22041588
Journal volume & issue
Vol. 22, no. 4
p. 1588

Abstract

Read online

HIV-1 infects T cells, but the most frequent AIDS-related lymphomas are of B-cell origin. Molecular mechanisms of HIV-1-induced oncogenic transformation of B cells remain largely unknown. HIV-1 Tat protein may participate in this process by penetrating and regulating gene expression in B cells. Both immune and cancer cells can reprogram communications between extracellular signals and intracellular signaling pathways via the Akt/mTORC1 pathway, which plays a key role in the cellular response to various stimuli including viral infection. Here, we investigated the role of HIV-1 Tat on the modulation of the Akt/mTORC1 pathway in B cells. We found that HIV-1 Tat activated the Akt/mTORC1 signaling pathway; this leads to aberrant activation of activation-induced cytidine deaminase (AICDA) due to inhibition of the AICDA transcriptional repressors c-Myb and E2F8. These perturbations may ultimately lead to an increased genomic instability and proliferation that might cause B cell malignancies.

Keywords